• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Axogen, Inc. - Common Stock (NQ: AXGN )

    16.73 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 230
    Open 16.73
    Bid (Size) 16.50 (10)
    Ask (Size) 17.90 (3)
    Prev. Close 16.73
    Today's Range 16.73 - 16.73
    52wk Range 5.550 - 17.23
    Shares Outstanding 41,397,053
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
    From Axogen, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +142.11%
    +142.11%
    1 Month
    +22.92%
    +22.92%
    3 Month
    +21.23%
    +21.23%
    6 Month
    +131.72%
    +131.72%
    1 Year
    +139.34%
    +139.34%

    More News

    Read More
    Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen Earnings Preview
    Via Benzinga
    Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
    From Axogen, Inc.
    Via GlobeNewswire
    CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
    From CytoSorbents
    Via GlobeNewswire
    AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Axogen, Inc. Announces New Leadership Appointments
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen, Inc. Reports Second Quarter 2024 Financial Results
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
    From Axogen, Inc.
    Via GlobeNewswire
    Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference
    From Axogen, Inc.
    Via GlobeNewswire
    AXGN Stock Earnings: Axogen Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Axogen, Inc Reports First Quarter 2024 Financial Results
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
    From Axogen, Inc.
    Via GlobeNewswire
    Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
    From Axogen, Inc.
    Via GlobeNewswire
    Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q4 2023
    Via InvestorPlace
    Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
    From Axogen, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 5, 2024
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.